End-of-day quote
Shenzhen S.E.
06:00:00 2024-04-29 pm EDT
|
5-day change
|
1st Jan Change
|
9.9
CNY
|
-1.69%
|
|
-2.17%
|
-5.35%
|
Fiscal Period: December |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
2,873
|
19,134
|
13,208
|
11,065
|
10,653
|
-
|
-
|
Enterprise Value (EV)
1 |
2,873
|
19,134
|
13,208
|
11,065
|
10,653
|
10,653
|
10,653
|
P/E ratio
|
24.8
x
|
12.2
x
|
6.1
x
|
22.3
x
|
13.5
x
|
11.4
x
|
8.76
x
|
Yield
|
-
|
-
|
-
|
-
|
2.58%
|
3.08%
|
3.38%
|
Capitalization / Revenue
|
-
|
-
|
0.64
x
|
0.65
x
|
0.61
x
|
0.61
x
|
0.6
x
|
EV / Revenue
|
-
|
-
|
0.64
x
|
0.65
x
|
0.61
x
|
0.61
x
|
0.6
x
|
EV / EBITDA
|
-
|
-
|
3.62
x
|
5.08
x
|
4.96
x
|
4.91
x
|
-
|
EV / FCF
|
-
|
-
|
-
|
-
|
-9.71
x
|
10.6
x
|
7.8
x
|
FCF Yield
|
-
|
-
|
-
|
-
|
-10.3%
|
9.47%
|
12.8%
|
Price to Book
|
-
|
-
|
2.82
x
|
1.68
x
|
1.51
x
|
1.38
x
|
1.23
x
|
Nbr of stocks (in thousands)
|
897,867
|
897,867
|
897,867
|
1,057,867
|
1,057,867
|
-
|
-
|
Reference price
2 |
3.200
|
21.31
|
14.71
|
10.46
|
10.07
|
10.07
|
10.07
|
Announcement Date
|
4/29/21
|
4/8/22
|
3/12/23
|
4/12/24
|
-
|
-
|
-
|
Fiscal Period: December |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
-
|
-
|
20,713
|
17,042
|
17,467
|
17,509
|
17,715
|
EBITDA
1 |
-
|
-
|
3,646
|
2,179
|
2,146
|
2,169
|
-
|
EBIT
1 |
-
|
-
|
2,952
|
1,059
|
1,370
|
1,622
|
2,182
|
Operating Margin
|
-
|
-
|
14.25%
|
6.22%
|
7.84%
|
9.27%
|
12.32%
|
Earnings before Tax (EBT)
1 |
-
|
-
|
2,969
|
968.8
|
1,370
|
1,622
|
2,182
|
Net income
1 |
115.8
|
1,569
|
2,164
|
453.1
|
787.5
|
937
|
1,214
|
Net margin
|
-
|
-
|
10.45%
|
2.66%
|
4.51%
|
5.35%
|
6.85%
|
EPS
2 |
0.1290
|
1.748
|
2.411
|
0.4698
|
0.7450
|
0.8850
|
1.150
|
Free Cash Flow
1 |
-
|
-
|
-
|
-
|
-1,097
|
1,009
|
1,367
|
FCF margin
|
-
|
-
|
-
|
-
|
-6.28%
|
5.76%
|
7.71%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
46.53%
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
107.71%
|
112.57%
|
Dividend per Share
2 |
-
|
-
|
-
|
-
|
0.2600
|
0.3100
|
0.3400
|
Announcement Date
|
4/29/21
|
4/8/22
|
3/12/23
|
4/12/24
|
-
|
-
|
-
|
Fiscal Period: December |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
-
|
-
|
-
|
-
|
-1,097
|
1,009
|
1,367
|
ROE (net income / shareholders' equity)
|
-
|
-
|
60.8%
|
8.24%
|
11.3%
|
12.4%
|
14%
|
ROA (Net income/ Total Assets)
|
-
|
-
|
10.7%
|
-
|
3.7%
|
4.3%
|
-
|
Assets
1 |
-
|
-
|
20,266
|
-
|
21,284
|
21,791
|
-
|
Book Value Per Share
2 |
-
|
-
|
5.210
|
6.210
|
6.690
|
7.290
|
8.190
|
Cash Flow per Share
2 |
-
|
-
|
4.300
|
1.540
|
1.770
|
1.680
|
-
|
Capex
1 |
-
|
-
|
2,203
|
1,492
|
1,365
|
1,315
|
1,501
|
Capex / Sales
|
-
|
-
|
10.64%
|
8.75%
|
7.81%
|
7.51%
|
8.47%
|
Announcement Date
|
4/29/21
|
4/8/22
|
3/12/23
|
4/12/24
|
-
|
-
|
-
|
Last Close Price
10.07
CNY Average target price
12.26
CNY Spread / Average Target +21.75% Consensus |
1st Jan change
|
Capi.
|
---|
| -3.73% | 1.47B | | +4.70% | 75.24B | | +1.20% | 46.91B | | -3.94% | 30.9B | | +12.30% | 18.41B | | -9.85% | 11.65B | | +8.37% | 11.45B | | -6.77% | 9.85B | | +5.92% | 9.45B | | +5.61% | 9.37B |
Diversified Chemicals
|